Results 281 to 290 of about 47,434 (363)

Genomic landscape of entrectinib resistance from ctDNA analysis in STARTRK-2

, 2019
Robert C. Doebele, Rafał Dziadziuszko, Alexander Drilon, Alice T. Shaw, Jennifer Moriatis Wolf, Anna F. Farago, Lucas Dennis, Todd Riehl, Bonnie Simmons, Chew Wun Wu, Chia‐Jung Chang, Voleak Choeurng, Tim Wilson   +12 more
openalex   +1 more source

New Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor Committee

Pediatric Blood &Cancer, Volume 72, Issue 10, October 2025.
ABSTRACT Outcomes for relapsed Ewing sarcoma remain consistently poor. Continued efforts to consider creative new approaches for the treatment of relapsed Ewing sarcoma are needed. The Children's Oncology Group Bone Tumor Committee convened a New Strategies for Ewing Sarcoma Task Force to systematically evaluate agents for inclusion in future Phase II ...
Jessica D. Daley, Susan L. Whiteway, Christine M. Heske, Filemon S. Dela Cruz, Sarah B. Whittle, Sarah Cohen‐Gogo, Anderson B. Collier, Ajay Gupta, Joyce Ohm, Andrew Clark, Alice Soragni, Elizabeth Lawlor, Bhuvana Setty, Patrick J. Grohar, Katie Janeway, Damon R. Reed, Emily K. Slotkin, Kelly M. Bailey   +17 more
wiley   +1 more source

Clinical applications of cell-free DNA-based liquid biopsy analysis. [PDF]

Transl Oncol
Yazaki S, Tokura M, Aiba H, Kojima Y, Shiraishi K.   +4 more
europepmc   +1 more source

Mutation tracking in circulating tumour DNA (ctDNA) detects minimal residual disease (MRD) in patients with localized colorectal cancer (CRC) and identifies those at high risk of recurrence regardless of stage, lack of CDX2 expression and CMS subtype

, 2019
N. Tarazona Llavero, Francisco Gimeno-Valiente, Valentina Gambardella, Marisol Huerta, Susana Roselló, Gema Bruixola, Elisa Fontana, Carolina Martínez‐Ciarpaglini, S. Zúñiga, Pilar Rentero-Garrido, Tania Fleitas, Federica Papaccio, D Moro, Vicent Fonollosa Plá, Gift Nyamundanda, Josefa Castillo, A. Sadanadam, Alejandro Espí, Desamparados Roda, Andrés Cervantes   +19 more
openalex   +1 more source

Detection of ctDNA in the plasma of patients with papillary thyroid carcinoma

, 2019
Huiqiang Li, Jiangman Zhao, Jianhua Zhang, Congren Wang, Mingzhu Li, Shouxin Wu, Zijian Su, Qunxiong Pan   +7 more
openalex   +2 more sources

Liquid clues: tracking early-stage breast cancer with ctDNA - a mini review. [PDF]

Front Oncol
Easaw S, Hsu J, Steuerwald N, Heeke AL.
europepmc   +1 more source

Real‐World Outcomes of Brigatinib Compared to Alectinib as a Second‐Line Therapy After Crizotinib in Advanced Anaplastic Lymphoma Kinase Positive Non‐Small Cell Lung Cancer Patients

Thoracic Cancer, Volume 16, Issue 19, October 2025.
In this prospective multicenter study of crizotinib‐refractory ALK‐positive NSCLC, the systemic efficacy of brigatinib and alectinib was not significantly different. Differences in intracranial progression‐free survival and response rates were observed, with outcomes appearing more favorable for alectinib.
Min Jee Kim, Hyun Seok Kwak, Eun Nim Koh, Cheol‐Kyu Park, Young‐Chul Kim, In‐Jae Oh, Seung Joon Kim, Jun Hyeok Lim, Jeong‐Seon Ryu, Chang Min Choi   +9 more
wiley   +1 more source

Prognostic Value of Circulating Tumor DNA in HR+/HER2- Stage I-III Breast Cancer: A Systematic Review. [PDF]

Cancers (Basel)
Ajjawi I, Rozenblit M, Rios-Hoyo A, Lustberg MB.   +3 more
europepmc   +1 more source

The Black Hole of Immune Checkpoint Blocking Therapy for Gastric Cancer: Hyperprogressive Disease

Cancer Science, Volume 116, Issue 10, Page 2630-2639, October 2025.
This review summarizes the mechanisms, predictive biomarkers, prevention, and treatment methods of HPD after immune checkpoint blockade therapy, providing a theoretical basis for making a judgment on the efficacy of ICI treatment for gastric cancer.
Zhuan‐Fang Wang, Chen‐Hui Ma, Ewetse Paul Maswikiti, Qin‐Ying Han, Li‐Juan He, Ben Liu, Zhi‐Jian Han, Hao Chen   +7 more
wiley   +1 more source

Clinical validation of liquid biopsy-RECIST (LB-RECIST) in metastatic colorectal cancer (mCRC) patients: findings from the PLATFORM-B study. [PDF]

ESMO Open
Martelli V, Vidal J, Gibert J, Fernández-Rodríguez MC, Linares J, García-Alfonso P, Páez D, Alonso V, Gomez-España MA, Guix M, Santos C, Duran G, Élez E, Garcia-Carbonero R, Ferreiro R, Pineda E, Sastre J, Cano MT, Manzano JL, Losa F, Aranda E, Rivera F, Sibilio A, Toledo R, Tabernero J, Salazar R, Bellosillo B, Montagut C, Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).   +28 more
europepmc   +1 more source